IGMS (IGM Biosciences Inc.) Company Cash Volume

Graphic logo of igmbio.com (IGMS)

Laboratory robotization for IgM antibody synthesis ensures high process precision for IGM Biosciences, Inc. (IGMS). The company's cash position confirms this status, with the metric standing at 0.06. The asset's resilience is based on the autonomy of the medical cycle, although geopolitical tensions may hinder international testing and chemical supplies.

IGMS - igmbio.com Company Liquid Assets over the range 07/04/2022 - 08/24/2025

Analytical breakdowns and data insights for company IGM Biosciences, Inc. (IGMS)

- current price and projected stock value:
Fundamental company analysis:igmbio.com
Signature product of IGM Bio

This indicator reflects the current volume of liquid assets, determining the issuer's ability to cover operating expenses and liabilities. For IGM Biosciences, Inc. (IGMS), this resource is critical as it funds costly oncology R&D processes regardless of market cycles. By analyzing the amount of cash reserves, an investor assesses the "margin of safety" before clinical trial results are obtained. A stable cash balance minimizes the risks of underfunding development. Long-term liquidity growth confirms the sustainability of the business model.

Main competitors

Company Cash Volume ARGX|BioNTech - Company Cash and Cash Equivalents|Company Cash Volume ABVX (abivax.com)|Company Cash Balance ADMA|Protagonist Therapeutics, Inc. - Company Cash Volume|Company Cash Reserve Immunovant, Inc.|KNSA: Company Cash Volume|GRFS - Company Liquid Assets|ADPT (Adaptive Biotechnologies Inc.) - Company Cash Volume|CLDX: Company Cash Balance|Company Cash Funds Aurinia Pharmaceuticals Inc. (AUPH)|Company Cash Funds BCRX (BioCryst Pharmaceuticals Inc)|Company Cash Volume VERA (Vera Corp)|Company Total Cash Amount DNTH (Dianthus Therapeutics)|PHVS - Company Cash Funds|ABCL: Company Cash Funds|TRML: Company Cash Volume|Company Cash on Hand Precigen, Inc.|Company Cash on Hand PHAR|Nektar Therapeutics - Company Total Cash Volume|Company Cash Funds Upstream Bio Corp (UPB)|Company Cash on Hand Zenas Biopharma ZBIO|Company Cash Funds Immunome Bio IMNM|GOSS: Company Cash and Cash Equivalents|kalvista.com - Company Cash Volume|SEPN (septerna.com) - Company Cash and Cash Equivalents|PVLA (Pieris Pharmaceuticals) - Company Cash on Hand|Savara - Company Cash Balance|RIGL (Rigel Corp) - Company Cash Volume|Company Cash Volume AnaptysBio Corp|Company Cash Funds astriatx.com (ATXS)|Company Cash on Hand enGene ENGN|Company Cash Funds RAPT Therapeutics, Inc. RAPT|JBIO - Company Cash on Hand|Aclaris Therapeutics Inc. - Company Cash Volume|KYTX - Company Cash Volume|TLSA (Tiziana Life Sciences PLC) - Company Cash on Hand|cabalettabio.com (CABA) - Company Cash Volume|Company Cash Funds Ventyx Biosciences|THTX (Theratechnologies) - Company Total Cash Amount|Company Cash on Hand AVTX (Avalo Therapeutics Inc.)|Company Cash Funds ELDN (Eledon)|Company Cash Volume AGEN (Agenus, Inc)|Company Liquid Assets climbbio.com (CLYM)|zurabio.com - Company Cash Volume|ATYR - Company Cash Volume|ADAG: Company Cash Volume|Ikena Oncology, Inc. (IMA) - Company Cash Volume|STTK (Shattuck Therapeutics) - Company Cash Volume|Company Cash Reserve equilliumbio.com EQ|Company Cash Volume CNTB|IMUX - Company Cash Reserve|Company Cash Funds Atara Biotherapeutics ATRA|Company Liquid Assets InflaRx N.V. (IFRX)|XFOR: Company Cash on Hand|adicetbio.com (ACET) - Company Cash on Hand|CELU: Company Cash Volume|Company Cash Reserve INmune Bio (INMB)|Company Cash Funds Barinthus Bio|Company Cash and Cash Equivalents KZR (Kezar Life Sciences, Inc)|Company Cash on Hand SABS (SAB Biotherapeutics Inc)|Akari Therapeutics - Company Cash and Cash Equivalents|Enlivex Therapeutics Ltd - Company Cash on Hand|Company Cash Balance QTTB|GOVX - Company Cash Funds|Company Cash Reserve Edesa|IBIO: Company Cash Volume|Company Cash Reserve Carisma Therapeutics Inc (CARM)|Company Cash Funds XTL Biopharmaceuticals, Ltd.|Company Cash Funds BOLT|Company Cash on Hand HCWB (HCW Biologics, Inc.)|Company Total Cash Amount APVO|AIM ImmunoTech - Company Cash on Hand|Company Cash Balance ADTX|GRI - Company Cash Funds|XRTX (XORTX Therapeutics Inc) - Company Cash and Cash Equivalents|HIND: Company Cash Volume|REVB (Revelation Bio) - Company Cash Funds|Company Cash Funds Indaptus|Scinai Immunotherapeutics (SCNI) - Company Liquid Assets|Company Cash Volume CALI|Company Cash on Hand Affimed NV AFMD|Company Cash Funds Allakos Inc ALLK|HOOK (HOOKIPA) - Company Total Cash Volume|iTeos Pharma - Company Cash Volume|Company Liquid Assets oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Company Cash Funds|Company Cash and Cash Equivalents THRD